Researchers have developed a breakthrough model using CRISPR to track leukemia development from stem cells. The study reveals unexpected plasticity in cancer progression and opens new avenues for therapeutic intervention.
Scientists have constructed a novel multi-epitope vaccine targeting Brucella species through advanced bioinformatics approaches. The vaccine candidate demonstrates strong potential in computational analyses, though experimental validation remains necessary.
Researchers have reportedly developed a promising multi-epitope vaccine candidate against Brucella species using reverse vaccinology approaches, according to findings published in Scientific Reports. The comprehensive bioinformatics strategy employed multiple computational tools to design a vaccine that sources indicate could provide broad protection against the pathogenic bacteria responsible for brucellosis.
